open access

Vol 7 (2022): Continuous Publishing
Case report
Published online: 2022-09-05
Get Citation

Recurrent haemorrhage following chalazion incision and curettage in a patient with chronic kidney disease

Soumya Ramani1, Chris D. Pius1
·
Ophthalmol J 2022;7:114-116.
Affiliations
  1. Department of Ophthalmology, MS Ramaiah Medical College Hospital, Bangalore, India

open access

Vol 7 (2022): Continuous Publishing
CASE REPORTS
Published online: 2022-09-05

Abstract

Chalazia are commonly seen as eyelid lesions caused by inflammation of the meibomian glands. Most chalazia resolve spontaneously or with medical treatment. Incision and curettage are required for chalazia that persist even after medical management. Even this simple outpatient department (OPD) procedure, if not performed with utmost caution and considering all the systemic factors, can have dire consequences.

We present a case report of a patient with known hypertension and stage five chronic kidney disease (CKD) on maintenance hemodialysis presented with multiple chalazia on the lower lids of both eyes. He underwent an uneventful chalazion incision and curettage for both the eyes three days apart.

Hemodialysis was done five days later, after which the patient had profuse bleeding from the wound site. Bleeding was temporarily controlled with a tight pressure patch, but the patient continued to have intermittent bleeding the next day. All hematological parameters were within normal limits except for slightly decreased hemoglobin, and the patient was treated systemically.

Knowledge and treatment of the factors impairing hemostasis in patients with CKD help reduce the risk of perioperative bleeding. It is essential to be vigilant in such a situation to manage any untoward complications.

Abstract

Chalazia are commonly seen as eyelid lesions caused by inflammation of the meibomian glands. Most chalazia resolve spontaneously or with medical treatment. Incision and curettage are required for chalazia that persist even after medical management. Even this simple outpatient department (OPD) procedure, if not performed with utmost caution and considering all the systemic factors, can have dire consequences.

We present a case report of a patient with known hypertension and stage five chronic kidney disease (CKD) on maintenance hemodialysis presented with multiple chalazia on the lower lids of both eyes. He underwent an uneventful chalazion incision and curettage for both the eyes three days apart.

Hemodialysis was done five days later, after which the patient had profuse bleeding from the wound site. Bleeding was temporarily controlled with a tight pressure patch, but the patient continued to have intermittent bleeding the next day. All hematological parameters were within normal limits except for slightly decreased hemoglobin, and the patient was treated systemically.

Knowledge and treatment of the factors impairing hemostasis in patients with CKD help reduce the risk of perioperative bleeding. It is essential to be vigilant in such a situation to manage any untoward complications.

Get Citation

Keywords

chalazion; curettage; hemorrhage; bleeding; chronic kidney disease; hemodialysis

About this article
Title

Recurrent haemorrhage following chalazion incision and curettage in a patient with chronic kidney disease

Journal

Ophthalmology Journal

Issue

Vol 7 (2022): Continuous Publishing

Article type

Case report

Pages

114-116

Published online

2022-09-05

Page views

3729

Article views/downloads

519

DOI

10.5603/OJ.2022.0019

Bibliographic record

Ophthalmol J 2022;7:114-116.

Keywords

chalazion
curettage
hemorrhage
bleeding
chronic kidney disease
hemodialysis

Authors

Soumya Ramani
Chris D. Pius

References (5)
  1. Perry HD, Serniuk RA. Conservative treatment of chalazia. Ophthalmology. 1980; 87(3): 218–221.
  2. Procope JA, Kidwell Jr. Delayed postoperative hemorrhage complicating chalazion surgery. J National Med Assoc. 1994; 86(11): 865.
  3. Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial. 2006; 19(4): 317–322.
  4. Galbusera M, Remuzzi G, Boccardo P. Treatment of bleeding in dialysis patients. Semin Dial. 2009; 22(3): 279–286.
  5. Patriarcheas V, Pikoulas A, Kostis M, et al. Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management. Cureus. 2020; 12(3): e7385.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Publisher: VM Media Group sp. z o.o., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 310 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl